See more : Yue Da International Holdings Limited (0629.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Fractyl Health, Inc. Common Stock (GUTS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fractyl Health, Inc. Common Stock, a leading company in the Biotechnology industry within the Healthcare sector.
- Thunder Mountain Gold, Inc. (THMG) Income Statement Analysis – Financial Results
- Mos Food Services, Inc. (8153.T) Income Statement Analysis – Financial Results
- Alchemy Resources Limited (ALY.AX) Income Statement Analysis – Financial Results
- Arlington Asset Investment Corp. (AAIC) Income Statement Analysis – Financial Results
- Mimaki Engineering Co., Ltd. (6638.T) Income Statement Analysis – Financial Results
Fractyl Health, Inc. Common Stock (GUTS)
About Fractyl Health, Inc. Common Stock
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 120.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 77.00K | 452.00K | 676.00K | 770.00K | 893.00K |
| Gross Profit | 43.00K | -452.00K | -676.00K | -770.00K | -893.00K |
| Gross Profit Ratio | 35.83% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 38.04M | 34.35M | 26.44M | 22.43M | 20.89M |
| General & Administrative | 0.00 | 15.03M | 10.49M | 6.53M | 9.03M |
| Selling & Marketing | 0.00 | -452.00K | -676.00K | -770.00K | -893.00K |
| SG&A | 12.84M | 14.58M | 9.82M | 5.76M | 8.14M |
| Other Expenses | 0.00 | 2.31M | -9.00K | -1.00K | 0.00 |
| Operating Expenses | 50.88M | 48.93M | 36.25M | 28.19M | 29.03M |
| Cost & Expenses | 50.96M | 49.39M | 36.93M | 28.96M | 29.92M |
| Interest Income | 1.26M | 797.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 1.44M | 1.50M | 635.00K |
| Depreciation & Amortization | 286.00K | 452.00K | 676.00K | 770.00K | 893.00K |
| EBITDA | -50.55M | -48.93M | -36.25M | -28.19M | -29.03M |
| EBITDA Ratio | -42,125.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -50.84M | -49.39M | -36.93M | -28.96M | -29.92M |
| Operating Income Ratio | -42,363.33% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -26.26M | 2.93M | -1.81M | -1.52M | -673.00K |
| Income Before Tax | -77.09M | -46.45M | -38.74M | -30.48M | -30.59M |
| Income Before Tax Ratio | -64,242.50% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -77.09M | -46.45M | -38.74M | -30.48M | -30.59M |
| Net Income Ratio | -64,242.50% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -1.98 | -0.98 | -0.81 | -0.64 | -0.64 |
| EPS Diluted | -1.98 | -0.98 | -0.81 | -0.64 | -0.64 |
| Weighted Avg Shares Out | 47.61M | 47.61M | 47.61M | 47.61M | 47.61M |
| Weighted Avg Shares Out (Dil) | 47.61M | 47.61M | 47.61M | 47.61M | 47.61M |
Another Huge Buffett Purchase Highlights Recent Insider Buying
U.S. IPO Weekly Recap: Amer Sports' Billion-Dollar U.S. IPO Leads A Week Of Large Listings
Fractyl Health valued at $654.6 mln in tepid debut
Fractyl Health prices US IPO below range to raise $110 mln
Fractyl Health Announces Pricing of Initial Public Offering
GUTS IPO News: 5 Things to Know as Fractyl Health Plans to Go Public
Fractyl Health targets up to $762 mln valuation in US IPO
Fractyl Health Aims For $100 Million IPO Raise
Source: https://incomestatements.info
Category: Stock Reports